The antiretroviral drugs provided by the study were lopinavir/ritonavir (Kaletra), d4T (stavudine; Zerit), and tenofovir/emtricitabine (Truvada), ...
... Zerit), and the additional risk due to abacavir and ddI largely disappeared after the drugs were discontinued. These findings were drawn from the large, ...
... Zerit for six months or more was associated with asymptomatic narrowing of the coronary artery (p = 0.02) as was six months or more of treatment with ...
According to the Fair Pricing Coalition, the company markets four HIV drugs: Zerit, a 15-year-old drug whose sales have plummeted in recent years because of ...
The coalition fears other drugmakers could follow BMS’ lead. The company markets four HIV drugs: Zerit, Sustiva, Atripla and Reyataz.
... particularly ddI (didanosine, Videx) and d4T (stavudine, Zerit); an editorial published in the same issue comments on the surprising EuroSIDA findings. ...
... particularly ddI (didanosine, Videx) and d4T (stavudine, Zerit); an editorial published in the same issue comments on the surprising EuroSIDA findings. ...
... studies have consistently shown that therapy with the so-called ‘d’ drugs (dideoxynucleosides), particularly d4T (stavudine, Zerit), are associated with ...
Lamivudine is sold by GSK under the brand name Epivir and EPivir-HBV, while Stavudine is marketed by Bristol Myers Squibb under the brand name Zerit. ...
Antiretrovirals including d4t (stavudine, Zerit) and ddi (didanosine, Videx) have also been associated with steatosis (see aidsmap report here). ...